GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » EV-to-FCF

Sphere Medical Holding (LSE:SPHR) EV-to-FCF : 0.39 (As of Jun. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sphere Medical Holding's Enterprise Value is £-2.67 Mil. Sphere Medical Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2016 was £-6.79 Mil. Therefore, Sphere Medical Holding's EV-to-FCF for today is 0.39.

The historical rank and industry rank for Sphere Medical Holding's EV-to-FCF or its related term are showing as below:

LSE:SPHR's EV-to-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 26.54
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-12), Sphere Medical Holding's stock price is £0.00. Sphere Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.030. Therefore, Sphere Medical Holding's PE Ratio for today is At Loss.


Sphere Medical Holding EV-to-FCF Historical Data

The historical data trend for Sphere Medical Holding's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding EV-to-FCF Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -2.96 -1.60 -1.81 -0.91 -1.40

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sphere Medical Holding's EV-to-FCF

For the Medical Devices subindustry, Sphere Medical Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's EV-to-FCF falls into.



Sphere Medical Holding EV-to-FCF Calculation

Sphere Medical Holding's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-2.674/-6.793
=0.39

Sphere Medical Holding's current Enterprise Value is £-2.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2016 was £-6.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sphere Medical Holding's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/-0.030
=At Loss

Sphere Medical Holding's share price for today is £0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.030.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sphere Medical Holding EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.